Authors: | Wolchok, J. D.; Chiarion-Sileni, V.; Rutkowski, P.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Queirolo, P.; Dummer, R.; Butler, M. O.; Hill, A. G.; Postow, M. A.; Gaudy-Márqueste, C.; Lao, C. D.; Walker, J.; Márquez-Rodas, I.; Haanen, J. B. A. G.; Guidoboni, M.; Maio, M.; Carlino, M. S.; Sandhu, S.; Lebbé, C.; Ascierto, P. A.; Long, G. V.; Ritchings, C.; Nassar, A.; Askelson, M.; Benito, M. P.; Wang, W.; Hodi, F. S.; Larkin, J.; for the CheckMate 067 Investigators |
Article Title: | Final, 10-year outcomes with nivolumab plus ipilimumab in advanced melanoma |
Journal Title: | New England Journal of Medicine |
Volume: | 392 |
Issue: | 1 |
ISSN: | 0028-4793 |
Publisher: | Massachusetts Medical Society |
Date Published: | 2025-01-02 |
Start Page: | 11 |
End Page: | 22 |
DOI: | 10.1056/NEJMoa2407417 |
PROVIDER: | EBSCOhost |
PROVIDER: | cinahl plus with full text |
PUBMED: | 39282897 |
PMCID: | PMC12080919 |
DOI/URL: | |
Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF -- Source: CINAHL Plus with Full Text |